The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Sleep and Circadian Rhythm Regulation in Early Parkinson Disease
Open accessAbstract
IMPORTANCE: Sleep disturbances are recognized as a common nonmotor complaint in Parkinson disease but their etiology is poorly understood. OBJECTIVE: To define the sleep and circadian phenotype of patients with early-stage Parkinson disease. DESIGN, SETTING, AND PARTICIPANTS: Initial assessment of sleep characteristics in a large population-representative incident Parkinson disease cohort (N=239) at the University of Cambridge, England, followed by further comprehensive case-control sleep assessments in a subgroup of these patients (n=30) and matched controls (n=15). MAIN OUTCOMES AND MEASURES: Sleep diagnoses and sleep architecture based on polysomnography studies, actigraphy assessment, and 24-hour analyses of serum cortisol, melatonin, and peripheral clock gene expression (Bmal1, Per2, and Rev-Erbα). RESULTS: Subjective sleep complaints were present in almost half of newly diagnosed patients and correlated significantly with poorer quality of life. Patients with Parkinson disease exhibited increased sleep latency (P = .04), reduced sleep efficiency (P = .008), and reduced rapid eye movement sleep (P = .02). In addition, there was a sustained elevation of serum cortisol levels, reduced circulating melatonin levels, and altered Bmal1 expression in patients with Parkinson disease compared with controls. CONCLUSIONS AND RELEVANCE: Sleep dysfunction seen in early Parkinson disease may reflect a more fundamental pathology in the molecular clock underlying circadian rhythms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with healthy aged people, individuals with AD or PD show considerably lower melatonin rhythm amplitudes and excessive sleepiness, as well as other sleep–wake cycle disturbances, such as later sleep onsets254–258.”
From Rhythms of life: circadian disruption and brain disorders across the lifespan (2019) · cites this paper as [255]
In the citing paper
“This study shows significantly increased sleep latency, reduced sleep efficiency and reduced REM, along with reduced melatonin levels and a loss of BMAL1 serum expression rhythms, in a cohor of 239 individuals with PD.”
From Rhythms of life: circadian disruption and brain disorders across the lifespan (2019) · cites this paper as [255]
In the citing paper
“A lack of time-dependent variation in Bmal1 expression in PD patients was recently confirmed in another study (Breen et al., 2014).”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Breen et al., 2014
In the citing paper
“However, both studies reported decreased amplitude of melatonin secretion.”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Breen et al., 2014
In the citing paper
“Two other recent studies did not show alterations in the circadian phase of melatonin secretion (Breen et al., 2014, Videnovic et al., 2014a, Videnovic et al., 2014b).”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Breen et al., 2014
In the citing paper
“PD patients had elevated cortisol levels and reduced melatonin levels.”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Breen et al., 2014
In the citing paper
“While PD patients exhibit a preserved circadian rhythm of cortisol, the amount of cortsiol secreted is elevated in early PD (Breen et al., 2014).”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Breen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2007) · Cited by 6,530
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Dibner, C., Schibler, U., & Albrecht, U. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135821 · Cited by 2,421
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, К. R., & Schapira, A. H. V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,818
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
A clockwork web: circadian timing in brain and periphery, in health and disease
Hastings, M. H., Reddy, A. B., & Maywood, E. S. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1177 · Cited by 1,223
Self-citationSchenck, C. H., Boeve, B. F., & Mahowald, M. W. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.009 · Cited by 814
The circadian clock and pathology of the ageing brain
Kondratova, A. A., & Kondratov, R. V. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3208 · Cited by 482
Age-Related Decline in Circadian Output
Nakamura, T. J., Nakamura, W., Yamazaki, S., Kudo, T., Cutler, T., Colwell, C. S., & Block, G. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0451-11.2011 · Cited by 386
The human pineal gland and melatonin in aging and Alzheimer's disease
Wu, Y., & Swaab, D. F. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00196.x · Cited by 371
Cited by
Sorted by citations
Items 201–300 of 440
Alpha Synuclein Toxicity and Non-Motor Parkinson’s
Mazzotta, G. M., & Conte, C. (2024) · Cells · doi:10.3390/cells13151265 · Cited by 19
Baram, S., Karlsborg, M., Øzhayat, E. B., & Bakke, M. (2021) · Journal of Oral Rehabilitation · doi:10.1111/joor.13214 · Cited by 18
How Does Chronobiology Contribute to the Development of Diseases in Later Life
Stowe, T. A., & McClung, C. A. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s380436 · Cited by 20
Ibrahim, A., Högl, B., & Stefani, A. (2024) · Clinical and Translational Neuroscience · doi:10.3390/ctn8010011 · Cited by 19
Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study
Petschow, C., Scheef, L., Paus, S., Zimmermann, N., Schild, H. H., Klockgether, T., & Boecker, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164607 · Cited by 19
Molecular Crosstalk Between Circadian Rhythmicity and the Development of Neurodegenerative Disorders
Sharma, A., Lee, S., Kim, H., Yoon, H., Ha, S., & Kang, S. U. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00844 · Cited by 19
Circadian rhythm in prostate cancer: time to take notice of the clock
Zhu, W., He, Q., Feng, D., Wei, Q., & Yang, L. (2022) · Asian Journal of Andrology · doi:10.4103/aja202255 · Cited by 18
Mao, W., Zhao, C., Ding, H., Liang, K., Xue, J., Chan, P., & Cai, Y. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.01.027 · Cited by 18
Gjerstad, M. D., Alves, G. W., & Maple‐Grødem, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00961 · Cited by 18
Associations of sleep characteristics with alpha‐synuclein in cerebrospinal fluid in older adults
Wang, X., Liu, F., Bi, Y., Shen, X., Xu, W., Wang, J., Tan, L., & Yu, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51204 · Cited by 19
Treatment of sleeping disorders should be considered in clinical management of Parkinson's disease
dos Santos, A. B., Barreto, G. E., & Kohlmeier, K. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00273 · Cited by 18
Melatonin secretion in patients with Parkinson's disease receiving different-dose levodopa therapy
Kataoka, H., Saeki, K., Kurumatani, N., Sugie, K., & Obayashi, K. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.07.043 · Cited by 17
Early onset of sleep/wake disturbances in a progressive macaque model of Parkinson’s disease
Davin, A., Chabardès, S., Belaïd, H., Fagret, D., Djaileb, L., Dauvilliers, Y. A., Olivier David, A., Torres-Martinez, N., & Piallat, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-22381-z · Cited by 20
Sleeping difficulties and health-related quality of life in Parkinson's disease
Ylikoski, A., Martikainen, K. K., Siemiński, M., & Partinen, M. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12620 · Cited by 17
Effects of Kamikihito and Unkei-to on Sleep Behavior of Wild Type and Parkinson Model in Drosophila
Ito, K., Kawasaki, H., SUZUKI, T., Takahara, T., & Ishida, N. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00132 · Cited by 17
Analysis of Sleep Macrostructure in Patients Diagnosed with Parkinson’s Disease
Naranjo, J. E. G., Alfonso, M. A., Grass-Fernández, D., Chacón, L. M. M., Ibáñez, I. P., de la Fé, Y. R., & Sánchez, A. P. (2019) · Behavioral Sciences · doi:10.3390/bs9010006 · Cited by 17
Sleep as the Foundation of Brain Health
Ibrahim, A., Högl, B., & Stefani, A. (2025) · Seminars in Neurology · doi:10.1055/a-2566-4073 · Cited by 23
Exploring the nexus: Sleep disorders, circadian dysregulation, and Alzheimer’s disease
Khandayataray, P., & Murthy, M. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.066 · Cited by 19
Li, Z., Li, Y., Xu, X., Gu, J., Chen, H., & Gui, Y. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137139 · Cited by 17
The Park Sleep subtype in Parkinson’s disease: from concept to clinic
Tall, P., Qamar, M. A., Rosenzweig, I., Raeder, V., Sauerbier, A., Zach, H., Falup‐Pecurariu, C., & Chaudhuri, К. R. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2242786 · Cited by 17
Sekar, P. K. C., Thomas, S. M., & Veerabathiran, R. (2024) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2024.00085 · Cited by 16
How does healthy aging impact on the circadian clock?
Popa‐Wagner, A., Buga, A.-M., Dumitraşcu, D. I., Uzoni, A., Thome, J., & Coogan, A. N. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1424-2 · Cited by 17
Melone, M. A. B., Schettino, C., Dato, C., Capaldo, G., Sampaolo, S., & Iorio, G. D. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s116476 · Cited by 16
Regulation of Circadian Clock Genes on Sleep Disorders in Traumatic Brain Injury Patients
Zhanfeng, N., Hechun, X., Zhao, Z., Xu, H.-Y., & Fei, Z. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.06.122 · Cited by 16
Liu, Z., Liu, X., Fan, R., Jia, Y.-P., Zhang, Q., Gao, X.-Q., Wang, Y., Yang, M., Ji, L.-Z., Zhou, Y., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00724-2 · Cited by 17
The Rationale of Yoga in Parkinson's Disease: A Critical Review
Mailankody, P., Varambally, S. S., Thennarasu, K., & Pal, P. K. (2021) · Neurology India · doi:10.4103/0028-3886.329545 · Cited by 16
Marano, M., Rosati, J. D., Magliozzi, A., Casamassa, A., Rappa, A., Sergi, G., Iannizzotto, M., Yekutieli, Z., Vescovi, A. L., & Lazzaro, V. D. (2023) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2023.100094 · Cited by 16
Can chronopharmacology improve the therapeutic management of neurological diseases?
Sion, B., & Bégou, M. (2021) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12659 · Cited by 17
Association of sleep abnormalities in older adults with risk of developing Parkinson’s disease
Otaiku, A. I. (2022) · SLEEP · doi:10.1093/sleep/zsac206 · Cited by 15
Metabolic Basis of Circadian Dysfunction in Parkinson’s Disease
Rathor, P., & Ch, R. (2023) · Biology · doi:10.3390/biology12101294 · Cited by 17
Circadian neurogenetics and its implications in neurophysiology, behavior, and chronomedicine
Naveed, M., Chao, O. Y.-H., Hill, J. W., Yang, Y., Huston, J. P., & Cao, R. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105523 · Cited by 16
Meur, M. L., Pignatelli, J., Blasi, P., & Palomo, V. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115561 · Cited by 15
Namgyal, D., & Lim, C. (2025) · Nature and Science of Sleep · doi:10.2147/nss.s561326 · Cited by 16
Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease
Feigl, B., Lewis, S. J. G., & Rawashdeh, O. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12073-7 · Cited by 16
Parkinson’s disease and light: The bright and the Dark sides
Maggio, R., Vaglini, F., Rossi, M., Fasciani, I., Pietrantoni, I., Marampon, F., Corsini, G. U., Scarselli, M., & Millan, M. J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.06.013 · Cited by 14
Melatonin as a Chronobiotic/Cytoprotective Agent in REM Sleep Behavior Disorder
Cardinali, D. P., & Garay, A. D. C. (2023) · Brain Sciences · doi:10.3390/brainsci13050797 · Cited by 14
Shen, Y., Guo, X., Han, C., Wan, F. J., Ma, K., Guo, S., Wang, L., Xia, Y. F., Liu, L., Lin, Z., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2549-2 · Cited by 15
Therapeutic implications of circadian clocks in neurodegenerative diseases
Chang, Y. C., & Kim, J. Y. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24572 · Cited by 15
Stress system and related biomarkers in Parkinson's disease
Bougea, A. M., Stefanis, L., & Chrousos, G. P. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.07.004 · Cited by 14
Du, L., He, X., Fan, X., Wei, X., Xu, L., Liang, T., Wang, C., Ke, Y., & Yung, W. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108498 · Cited by 15
Molecular crosstalk between circadian clock and NLRP3 inflammasome signaling in Parkinson's disease
Huang, J., & Li, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24752 · Cited by 14
Sabbar, M., Dkhissi‐Benyahya, O., Benazzouz, A., & Lakhdar‐Ghazal, N. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00178 · Cited by 13
Altered dynamics of visual contextual interactions in Parkinson’s disease
Vanegas, M. I., Blangero, A., Galvin, J. E., Rocco, A. D., Quartarone, A., Ghilardi, M. F., & Kelly, S. P. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0085-5 · Cited by 12
New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson’s Disease
Kelberman, M. A., & Vazey, E. M. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0071-0 · Cited by 13
Biomarkers of Nonmotor Symptoms in Parkinson's Disease
Konno, T., Al‐Shaikh, R. H., Deutschlander, A. B., & Uitti, R. J. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.020 · Cited by 13
Sleep in Neurodegenerative Disorders
Malkani, R., & Attarian, H. (2015) · Current Sleep Medicine Reports · doi:10.1007/s40675-015-0016-x · Cited by 12
Chen, Y., Gao, Y., Sun, X., Wang, B. H., Qin, L., Wu, X., & Li, G. (2023) · Neuroepidemiology · doi:10.1159/000530982 · Cited by 12
Kasap, M., & Dwyer, D. S. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02348-6 · Cited by 13
Yang, S., Wan, Y., Wu, N., Song, L., Liu, Z., Zhao, J., Liu, Y., Liu, Z., & Gan, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.719885 · Cited by 12
Striatal norepinephrine efflux in l-DOPA-induced dyskinesia
Ostock, C. Y., Bhide, N., Goldenberg, A. A., George, J. A., & Bishop, C. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.01.010 · Cited by 12
Zhang, S., & Sehgal, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812536-6.00011-0 · Cited by 12
Mulak, A. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1701437 · Cited by 13
van den Heuvel, L., Lim, A. S. P., Visanji, N. P., Huang, J., Ghate, T., Mestre, T., AlDakheel, A., Connolly, B. S., Gasca‐Salas, C., Kern, D. S., et al. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171151 · Cited by 11
Pablo‐Fernández, E. D., & Warner, T. T. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00015-0 · Cited by 11
Influence of sleep disruption on protein accumulation in neurodegenerative diseases
Wang, X., Wang, R., & Li, J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.10 · Cited by 13
Evaluation of RNA Blood Biomarkers in Individuals at Risk of Parkinson’s Disease
Santiago, J. A., & Potashkin, J. A. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171155 · Cited by 11
Xu, M., Bohlen, J. K., Moore, C., Nipper, M. A., Finn, D. A., Jones, C. E., Lim, M. M., & Meshul, C. K. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24520 · Cited by 11
Sun, X., Tan, J., Chen, Y., Liu, Y., Dong, G., Yang, B., Li, N., Wang, L., Li, S., Chen, G., et al. (2023) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2023.114218 · Cited by 12
Bidirectional Relationship Between Circadian Rhythm and Frailty
Pan, Y., Zhu, F., Yuan, Y., Hu, G. M., Jiang, Y., & Dong, J. C. (2023) · Nature and Science of Sleep · doi:10.2147/nss.s436488 · Cited by 11
Predicting neurodegeneration from sleep related biofluid changes
Yang, Y., Kim, W. S., Michaelian, J. C., Lewis, S. J. G., Phillips, C. L., D'Rozario, A. L., Chatterjee, P., Martins, R. N., Grunstein, R. R., Halliday, G. M., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106369 · Cited by 10
I "Gut" Rhythm: the microbiota as a modulator of the stress response and circadian rhythms
Tofani, G. S. S., Clarke, G. A., & Cryan, J. F. (2025) · FEBS Journal · doi:10.1111/febs.17400 · Cited by 10
Sleep–wake and circadian disturbances in Parkinson disease: a short clinical guide
Baumann, C. R. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02039-3 · Cited by 10
The multimodal effect of circadian interventions in Parkinson's disease: A narrative review
Śmiłowska, K., van Wamelen, D. J., & Bloem, B. R. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105309 · Cited by 10
Su, H., Sun, Y., Yang, M., Wu, C., & Hsu, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311088 · Cited by 11
Circadian Rhythms in Aging and Age-Related Neurogenerative Disease
Zitting, K., & Yuan, R. K. (2025) · Current Sleep Medicine Reports · doi:10.1007/s40675-025-00336-w · Cited by 9
Objective sleep measures between patients with Parkinson's disease and community-based older adults
Kataoka, H., Saeki, K., Kurumatani, N., Sugie, K., & Obayashi, K. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.09.010 · Cited by 9
Uncovering the dynamics of a circadian-dopamine model influenced by the light–dark cycle
Kim, R., & Witelski, T. P. (2021) · Mathematical Biosciences · doi:10.1016/j.mbs.2021.108764 · Cited by 9
Jia, C., Tian, L., Cheng, C., Zhang, J., Al‐Nusaif, M., Li, T., Yang, H., Lin, Y., Li, S., & Le, W. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05053-7 · Cited by 10
Smith, S. K., & Musiek, E. S. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.005 · Cited by 10
Fifel, K., & Boer, T. D. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00019-4 · Cited by 10
Papp, A., Horvath, A. A., Virág, M., Tóth, Z., Borbély, C., Gombos, F., Szűcs, A., & Kamondi, A. (2022) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2022.01.010 · Cited by 9
Sleep Dysfunction in Movement Disorders: a Window to the Disease Biology
Standlee, J., & Malkani, R. G. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01220-8 · Cited by 11
Семенова, Е. И., Vlasov, I. N., Partevian, S. A., Rosinskaya, A. V., Rybolovlev, I. N., Slominsky, P. A., Shadrina, M. I., & Alieva, A. K. (2022) · Cells · doi:10.3390/cells11162599 · Cited by 9
[Cloning and sequencing of chitinase gene from Bacillus thuringiensis subsp israelensis].
Zhong, W., Jiang, L.-H., Yan, W.-Z., Cai, P.-Z., Zhi-xiong, Z., & Pei, Y. (2003) · PubMed · Cited by 9
The Central Clock in Patients With Parkinson Disease
Fifel, K., & Deboer, T. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2708 · Cited by 9
Fagiani, F., Baronchelli, E., Pittaluga, A., Pedrini, E., Scacchi, C., Govoni, S. M., & Lanni, C. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.937174 · Cited by 10
Polat, O. A., Gültekin, M., Şener, H., Ozer, F., & Arda, H. (2023) · Documenta Ophthalmologica · doi:10.1007/s10633-023-09945-8 · Cited by 8
REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage
Wang, X., Zhi, H., Zhang, Z., Li, J., & Guo, D. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02264-w · Cited by 8
Chen, D., Qian, S., Qian, W., Wu, M., Wang, X., Shen, H., Long, X., Ye, M., Gong, Y., & Chen, G. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s465898 · Cited by 8
Emerging preclinical interest concerning the role of circadian function in Parkinson’s disease
Willis, G. L., & Freelance, C. B. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.027 · Cited by 8
Seasonal variations of nonmotor symptoms in patients with Parkinson's disease in Southeast China
Wang, J., Xiong, K., Chao, J., Zhuang, S., Li, J., & Liu, C. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002276 · Cited by 8
Supplemental ambient lighting intervention to improve sleep in Parkinson's disease: A pilot trial
Yoo, A. S., Wise, A. H., Ortega, R. A., Raymond, D., Plitnick, B., Brons, J. A., Liang, J., Bressman, S., Yang, M., Pedler, D. R., et al. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107149 · Cited by 9
Wang, X., Wang, M., Zhi, H., Li, J., & Guo, D. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40388 · Cited by 7
Lee, S., Kim, J. H., Baek, J. W., Jung, K.-Y., Lee, Y., Koh, A., & Kim, H. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01040-w · Cited by 10
ENLITE PD - A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson’s Disease
Videnovic, A., Coffey, C. S., Klerman, E. B., Cudkowicz, M., Cho, H., Amara, A., Marder, K. S., Zee, P., Desir, C., Ernst, H., et al. (2025) · Movement Disorders · doi:10.1002/mds.70009 · Cited by 7
Ukraintseva, Y. V., & Kovalzon, V. M. (2016) · Human Physiology · doi:10.1134/s0362119716050170 · Cited by 7
CLOCK Genetic Variations Are Associated With Age-Related Changes in Sleep Duration and Brain Volume
Kim, S. E., Kim, S., Kim, H. J., Kim, R. E. Y., Kim, S.-A., Shin, C., & Lee, H. W. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab365 · Cited by 8
Kim, G. J., Mo, H., Liu, H., Okorie, M., Chen, S., Zheng, J., Li, H., Arkin, M. R., Huang, B., & Guo, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837756 · Cited by 7
Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise
Luthra, N., Christou, D. D., Clow, A., & Corcos, D. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1228444 · Cited by 7
The Central Clock in Patients With Parkinson Disease—Reply
Videnović, A., Breen, D. P., Barker, R. A., & Zee, P. C. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2711 · Cited by 7
Self-citationExogenous melatonin for Parkinson’s disease: ‘Waking up’ to the need for further trials
Breen, D. P., & Barker, R. A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.012 · Cited by 7
Self-citationSeasonality as a risk factor for deaths in Parkinson's disease
Fonseca, M. C. M., Sansone, D., Farah, D., FIORINI, A. C., Scorza, C. A., & Scorza, F. A. (2024) · Clinics · doi:10.1016/j.clinsp.2024.100506 · Cited by 7
Schindler, K. A., Torices, S., Schurhoff, N. A., Gallo, D. I., & Toborek, M. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115645 · Cited by 8
Sleep in neurodegenerative diseases: A focus on melatonin, melanin‐concentrating hormone and orexin
Guillot, S. J., Luppi, P., Dupuis, L., & Bolborea, M. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70085 · Cited by 6
Wyman, B. T., Adams, D. J., Hendrix, S. B., Groves, J., Croft, W., Ellison, N., Olanow, C. W., & Kieburtz, K. D. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00728 · Cited by 6
Jiang, G., Yuan, L., Liu, X., Wu, H., Yu, H., Zhang, W., Zhang, S., & Huang, Y. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2024.15 · Cited by 6
Zhang, X., Huang, S., & Kim, J. Y. (2024) · iScience · doi:10.1016/j.isci.2024.108829 · Cited by 6
Evaluating the Genetic Role of Circadian Clock Genes in Parkinson’s Disease
Xiang, Y., Huang, J., Wang, Y., Huang, X., Zeng, Q., Li, L., Zhao, Y., Pan, H., Xu, Q., Liu, Z., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03243-9 · Cited by 6
Khezri, M. R., Esmaeili, A., & Ghasemnejad‐Berenji, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00418 · Cited by 7
Evaluating and managing sleep disorders in the parkinson’s disease clinic
Gulyani, S., Salas, R. M. E., Mari, Z. K., Choi, S. I., Mahajan, A., & Gamaldo, C. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.05.001 · Cited by 6
Metadata
- Authors
- Breen, D. P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J. M., Reddy, A. B., & Barker, R. A.
- Affiliations
- University of Cambridge (GB)
- Royal Papworth Hospital (GB)
- Corresponding author
- Breen, David P.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2014-05-01
- Volume
- 71
- Issue
- 5
- Pages
- 589
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC4119609
- OpenAlex
- W1996955271
- Cited by
- 440
- References
- 35
- Citations by year
- 2026: 31 · 2025: 37 · 2024: 42 · 2023: 42 · 2022: 44 · 2021: 47 · 2020: 36 · 2019: 31 · 2018: 35 · 2017: 36 · 2016: 35 · 2015: 11 · 2014: 12
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- Kent Academic Repository (University of Kent) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Wellcome Trust (100574, 100333/Z/12/Z, 100333)
- Parkinson's UK (J-0801)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- Parkinson's disease, sleep disorders, circadian rhythm, early-stage Parkinson's disease, sleep architecture, sleep latency, REM sleep, serum cortisol, melatonin, clock genes, Bmal1, Per2, NR1D1, non-motor symptoms, quality of life
- MeSH terms
- Aged, Circadian Rhythm, Female, Humans, Male, Middle Aged, Parkinson Disease, Sleep, Cohort Studies, Case-Control Studies, Sleep Disorders, Circadian Rhythm, Early Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
